Clinical Trials on Nivolumab

Total 4 results

Namik Kemal University

Recruiting

CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab

Nivolumab Related Toxicity

Turkey
Peking University Cancer Hospital & Institute

Unknown

A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC

Carcinoma, Non-Small-Cell Lung | Docetaxel | Nivolumab

China
Centre Hospitalier Universitaire, Amiens

Not yet recruiting

Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers (NIVOCHIMLOC)

Squamous Cell Carcinoma of the Head and Neck | Paclitaxel | Nivolumab | Carboplatin

France
Intergroupe Francophone de Cancerologie Thoracique
Bristol-Myers Squibb

Completed

Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program (CLINIVO)

Non-small Cell Lung Cancer | Nivolumab | Long-term Adverse Effects

France

3

Subscribe